ResearcherMoffitt Cancer CenterNo recent work listed
John S. Macdonald
Matched on OpenAlex author ID A5103579071. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 2
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
1998: 1 trial · 1999: none · 2000: none · 2001: none · 2002: none · 2003: none · 2004: none · 2005: 1 trial · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper
Papers 3
- Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. Co-author DOI 10.1097/mpa.0000000000000710↗
- The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for panc… Co-author DOI 10.1016/j.ijrobp.2010.07.1993↗
- Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S… Co-author DOI 10.1245/s10434-011-1630-6↗
Trials 2
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William F. Regine · 3 shared papers, 1 shared trial, 1998–2016 · strength 0.11
- Paper Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. DOI 10.1097/mpa.0000000000000710↗
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- Al B. Benson · 3 shared papers, 1 shared trial, 1998–2016 · strength 0.11
- Paper Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. DOI 10.1097/mpa.0000000000000710↗
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- John Parker Hoffman · 2 shared papers, 2011 · strength 0.05
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- Christopher G. Willett · 2 shared papers, 2011 · strength 0.05
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- Ross Allen Abrams · 2 shared papers, 2011 · strength 0.05
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- Howard P. Safran · 2 shared papers, 2011 · strength 0.05
- Paper The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resect… DOI 10.1016/j.ijrobp.2010.07.1993↗
- Paper Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic ad… DOI 10.1245/s10434-011-1630-6↗
- Chandan Guha · 1 shared paper, 2016 · strength 0.05
- Xiyong Liu · 1 shared paper, 2016 · strength 0.05
- Yun Yen · 1 shared paper, 2016 · strength 0.05
- Hany Elsaleh · 1 shared paper, 2016 · strength 0.05
- James J. Farrell · 1 shared paper, 2016 · strength 0.05
- Andre A. Konski · 1 shared paper, 2011 · strength 0.03
- Timothy Norman Showalter · 1 shared paper, 2011 · strength 0.03
- Adam C. Berger · 1 shared paper, 2011 · strength 0.03
- Tyvin A. Rich · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.